Capecitabine

This publication has 29 references indexed in Scilit:

• Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients
  Cancer Chemotherapy and Pharmacology, 1999
• Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
  Journal of Clinical Oncology, 1998
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
  Published by Elsevier ,1998
• Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.
  Journal of Clinical Oncology, 1998
• Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts
  Biochemical Pharmacology, 1998
• Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
  1998
• Computer-Assisted Design of New Drugs Based on Retrometabolic Concepts
  SAR and QSAR in Environmental Research, 1998
• A Pilot Safety Study of Capecitabine, A New Oral Fluoropyrimidine, in Patients with Advanced Neoplastic Disease
  Tumori Journal, 1996
• 5′-Deoxy-S-fluorouridine Increases Daunorubicin Uptake in Multidrug-resistant Cells and Its Activity Is Related with P-gp 170 Expression
  Japanese Journal of Cancer Research, 1994
• 5'-DFUR, A NEW ANTI-CANCER AGENT ACTIVATED SELECTIVELY IN TUMOR-CELLS .3. TISSUE DISTRIBUTION OF 5'-DEOXY-5-FLUOROURIDINE AND DERIVED 5-FLUOROURACIL IN TUMOR-BEARING MICE AND RATS
  1980